Abstract
Influenza vaccination is less effective in elderly as compared to young individuals. Several studies have addressed the identification of immune biomarkers able to monitor or predict a protective humoral immune response to the vaccine. In this review, we summarize these data, with emphasis on the effects of aging on influenza vaccine-specific B cell responses in healthy individuals and patients with Type-2 Diabetes, HIV and cardiovascular diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 112-118 |
Number of pages | 7 |
Journal | Current Opinion in Immunology |
Volume | 29 |
Issue number | 1 |
DOIs | |
State | Published - Aug 2014 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology